Literature DB >> 20919394

The effect of Renal Failure and Dialysis on the Pharmacokinetics of Cefuroxime.

P E Gower, M R Kennedy, C H Dash.   

Abstract

Entities:  

Year:  1977        PMID： 20919394      PMCID： PMC1543214     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  4 in total

1.  Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens.

Authors:  C S Goodwin; C H Dash; J P Hill; A D Goldberg
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  The effect of impairment of renal function and haemodialysis on serum and urine levels of cephalexin.

Authors:  R R Bailey; P E Gower; C H Dash
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

4.  Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.

Authors:  C Chantler; E S Garnett; V Parsons; N Veall
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124
  4 in total
  3 in total

Review 1.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

2.  Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

Authors:  R W Bundtzen; R D Toothaker; O S Nielson; P O Madsen; P G Welling; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

3.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.